J. Neurochem.(2012) 120, 644–659. Abstract S100B is a calcium‐binding protein
concentrated in glial cells, although it has also been detected in definite extra‐neural cell …

S100B is a Ca2+‐binding protein mainly concentrated in astrocytes. Its levels in biological
fluids (cerebrospinal fluid, peripheral and cord blood, urine, saliva, amniotic fluid) are …

S100B is a calcium-binding protein mainly concentrated in astrocytes in the nervous system.
Its levels in biological fluids are recognized as a reliable biomarker of active neural distress …

S100B is a 21-kDa calcium-binding protein produced and released primarily by astrocytes in
the central nervous system (CNS), where it exerts neurotropic and gliotropic actions (1) …

S100B expression, particularly extracellular S100B, is used as a parameter of glial activation
and/or death in several situations of brain injury. Several immunoassays for S100B …

S100B is a calcium‐binding peptide produced mainly by astrocytes that exert paracrine and
autocrine effects on neurons and glia. Some knowledge has been acquired from in vitro and …

The diagnosis of perinatal insults currently relies on adequate documentation of general
medical and obstetric factors and on radiologic and laboratory assessments. The …

In recent years there has been a proliferation of interest in the brain‐specific protein S100B,
its many physiologic roles, and its behaviour in various neuropathologic conditions. Since …

In recent years, there has been an increased interest in the clinical use of brain markers. The
S100B is a calciumbinding peptide and is used as a parameter of glial activation and/or …

S100B, established as prevalent protein of the central nervous system, is a peripheral
biomarker for blood-brain barrier disruption and often also a marker of brain injury. However …